Linearis

Menu
en_US EN
en_US EN fr_CA FR

CREATING impact ACROSS THE ENTIRE AI LIFE SCIENCE CONTINUUM

The impact SPANS the ENTIRE health continuum

Linearis with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries to prevent, detect, and cure diseases through direct investments in innovative AI-powered life sciences companies.

Prevention

Fast
Accurate
Affordable

Early Diagnostics

Predictive response

Patient Monitoring

Personalized treatment

Drug Discovery

AI-Feedback loop for curative treatments

Noetik

$50M USD AI-drug discovery licensing with GSK

Noetik

NOETIK

AI is revolutionizing drug and therapeutic discovery, but relying on human experts for data labeling isn’t scalable. 

Noetik’s platform identifies novel targets for ther­a­peu­tics and predicts how patients will respond. It generates hundreds of terabytes of genomic, tran­scrip­tomic, and proteomic data on cells and tissues needed to power self-supervised, transformer-based predictive modeling in immuno-oncology.

Initiation Ph1/2b in basal cell carcinoma

FELDAN

FELDAN

A clinical-stage BioPharma company, specialized in the development of treatments based on intracellular delivery of therapeutics.

The overall investment supports the progression of Feldan’s lead candidate, FLD-103, a tailored delivery treatment for basal cell carcinoma currently in clinical trials, and help expand its pipeline program.

Non-Invasive Assessment of Biomarkers in the Eye. 510(k) & Health Canada approval

Back Title

ZILIA

Eyes provide a unique window into a person’s health due to their connections with the brain and the vascular system. 

Zilia is developing a groundbreaking technology harnessing imaging, spectrometry and AI to prevent, diagnose, and treat various ocular, neurological, and systemic diseases. Their biomarkers are providing healthcare professionals unprecedented clinical insight into various conditions. 

NOETIK is a frontier therapeutics company harnessing AI to deeply understand human biology and redefine clinical outcomes in oncology. Leveraging the largest proprietary multimodal oncology dataset of its kind, uniquely integrating spatial biology. Find out more at www.noetik.ai

 

Feldan is a clinical-stage biotech company specializing in the development of treatments based on the intracellular delivery of therapeutics with a proprietary peptide-based technology ensuring safe, rapid, and efficient local delivery of antisense oligonucleotides to cells. Find out more at www.feldan.com 

 

Zilia is measuring non-invasively the eyes by integrating advanced photonics and artificial intelligence to leverage direct connections between the eye biomarkers, the vascular system, the brain and overall health. Find out more at www.zilia.com